Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Tennant

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Antiviral activities of oral 1-O-hexadecylpropanediol-3-phosphoacyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infectionK Y Hostetler, J R Beadle, W E Hornbuckle, et al.
Hepatology (Baltimore, Md.)|December 29, 1999
Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infectionP J Cote, B E Korba, R H Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Evidence against a requisite role for defective virus in the establishment of persistent hepadnavirus infectionsR H Miller, R Girones, P J Cote, et al.
Journal of Virology|March 1, 1993
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucksH S Chen, S Kaneko, R Girones, et al.
Antiviral Therapy|March 22, 2000
Preclinical investigation of L-FMAU as an anti-hepatitis B virus agentC K Chu, F D Boudinot, S F Peek, et al.
The Journal of Infectious Diseases|October 27, 2001
Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infectionR J Colonno, E V Genovesi, I Medina, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1997
Depletion of mitochondrial DNA, destruction of mitochondria, and accumulation of lipid droplets result from fialuridine treatment in woodchucks (Marmota monax)W Lewis, B Griniuviene, K O Tankersley, et al.
Hepatology (Baltimore, Md.)|September 26, 2000
Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infectionP J Cote, I Toshkov, C Bellezza, et al.
Hepatology (Baltimore, Md.)|December 22, 2000
Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax)S F Peek, P J Cote, J R Jacob, et al.
Hepatology (Baltimore, Md.)|July 10, 1998
Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infectionB C Tennant, B H Baldwin, L A Graham, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Antimicrobial Agents and Chemotherapy|June 20, 2000
Antiviral activities of oral 1-O-hexadecylpropanediol-3-phosphoacyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infectionK Y Hostetler, J R Beadle, W E Hornbuckle, et al.
Hepatology (Baltimore, Md.)|December 29, 1999
Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infectionP J Cote, B E Korba, R H Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Evidence against a requisite role for defective virus in the establishment of persistent hepadnavirus infectionsR H Miller, R Girones, P J Cote, et al.
Journal of Virology|March 1, 1993
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucksH S Chen, S Kaneko, R Girones, et al.
Antiviral Therapy|March 22, 2000
Preclinical investigation of L-FMAU as an anti-hepatitis B virus agentC K Chu, F D Boudinot, S F Peek, et al.
The Journal of Infectious Diseases|October 27, 2001
Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infectionR J Colonno, E V Genovesi, I Medina, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 1, 1997
Depletion of mitochondrial DNA, destruction of mitochondria, and accumulation of lipid droplets result from fialuridine treatment in woodchucks (Marmota monax)W Lewis, B Griniuviene, K O Tankersley, et al.
Hepatology (Baltimore, Md.)|September 26, 2000
Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infectionP J Cote, I Toshkov, C Bellezza, et al.
Hepatology (Baltimore, Md.)|December 22, 2000
Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax)S F Peek, P J Cote, J R Jacob, et al.
Hepatology (Baltimore, Md.)|July 10, 1998
Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infectionB C Tennant, B H Baldwin, L A Graham, et al.
Pageof 11